Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2023 Filed Jun 15, 2023 19:34 UTC |
Dyer George Sinclair MitchellDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000084 · wk-form4_1686857659.xml · nonDerivative · entry 1 Dyer George Sinclair Mitchell · CIK 0001978362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,965 F1 · balance_after: Includes restricted stock awards totaling 1,965 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:32 UTC |
Pelizzon David RDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000082 · wk-form4_1686857532.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,781 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:30 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000080 · wk-form4_1686857427.xml · nonDerivative · entry 3 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 15,321 Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:30 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000080 · wk-form4_1686857427.xml · nonDerivative · entry 2 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,560 F1 · shares: On June 14, 2023, the reporting person had 1,497 of restricted stock which vested. Upon vesting these shares were distributed to the Donna Ruff DAP Trust dated July 30, 2020, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein. F2 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:30 UTC |
Ruf HaroldDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000080 · wk-form4_1686857427.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,057 Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 19:27 UTC |
Riccitelli Samuel DDirector
|
GrantCommon Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000078 · wk-form4_1686857259.xml · nonDerivative · entry 1 Riccitelli Samuel D · CIK 0001414839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,256 F1 · balance_after: Includes restricted stock awards totaling 3,560 shares. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 09:00 UTC |
Odle Gregory APresident of Scoliosis
|
SaleCommon Stock | 3,333 | $50.10 | $166,969.30 |
DisclosureSEC source: 0001425450-23-000056 · wf-form4_168268679480793.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,241 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 16:05 UTC |
Odle Gregory APresident of Scoliosis
|
SaleCommon Stock | 828 | $50.02 | $41,419.62 |
DisclosureSEC source: 0001425450-23-000054 · wf-form4_168253953538722.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,574 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 16:23 UTC |
Odle Gregory APresident of Scoliosis
|
SaleCommon Stock | 644 | $50.02 | $32,211.91 |
DisclosureSEC source: 0001425450-23-000052 · wf-form4_168236778360389.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,402 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 16:31 UTC |
Odle Gregory APresident of Scoliosis
|
GrantCommon Stock | 19,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000048 · wf-form4_167891225258569.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,046 F1 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 16:30 UTC |
Throdahl Mark CDirector
|
GrantCommon Stock | 12,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000047 · wf-form4_167891221922712.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,290 F1 · balance_after: Includes restricted stock awards totaling 27,906 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 20:32 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
GrantCommon Stock | 19,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000050 · wf-form4_167891232502189.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,144 F1 · balance_after: Includes restricted stock awards totaling 37,373 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 20:31 UTC |
Hauser Joseph WPres. Trauma & Def. Correction
|
GrantCommon Stock | 19,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000049 · wf-form4_167891229110123.xml · nonDerivative · entry 1 Hauser Joseph W · CIK 0001909181 · Pres. Trauma & Def. Correction 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,761 F1 · balance_after: Includes restricted stock awards totaling 37,372 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 20:30 UTC |
Hite FredDirector · COO and CFO
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000046 · wf-form4_167891219133767.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,623 F1 · balance_after: Includes restricted stock awards totaling 61,955 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 20:29 UTC |
Bailey David RDirector · President and CEO
|
GrantCommon Stock | 44,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000045 · wf-form4_167891216976496.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,897 F1 · balance_after: Includes restricted stock awards totaling 66,654 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 09:15 UTC |
Odle Gregory AExecutive Vice President
|
SaleCommon Stock | 3,421 | $44.03 | $150,618.42 |
DisclosureSEC source: 0001425450-23-000032 · wf-form4_167819850578407.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,429 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 18,293 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 09:13 UTC |
Throdahl Mark CDirector
|
SaleCommon Stock | 4,515 | $43.83 | $197,871.68 |
DisclosureSEC source: 0001425450-23-000030 · wf-form4_167819839045203.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,024 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 15,640 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 14:17 UTC |
Bailey David RDirector · President and CEO
|
SaleCommon Stock | 4,052 | $44.40 | $179,910.42 |
DisclosureSEC source: 0001425450-23-000036 · wf-form4_167819866698810.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,453 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 22,210 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 14:16 UTC |
Hite FredDirector · COO and CFO
|
SaleCommon Stock | 4,099 | $43.77 | $179,396.83 |
DisclosureSEC source: 0001425450-23-000034 · wf-form4_167819858308744.xml · nonDerivative · entry 1 Hite Fred · CIK 0001298644 · Director · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,623 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 31,955 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 14:11 UTC |
Gerritzen Daniel JGeneral Counsel and Secretary
|
SaleCommon Stock | 3,315 | $44.62 | $147,916.29 |
DisclosureSEC source: 0001425450-23-000028 · wf-form4_167819830025469.xml · nonDerivative · entry 1 Gerritzen Daniel J · CIK 0001718972 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,527 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 17,756 shares. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 19:34 UTC |
Hauser Joseph WSr VP & GM Trauma & Deformity
|
SaleCommon Stock | 2,554 | $43.74 | $111,704.81 |
DisclosureSEC source: 0001425450-23-000026 · wf-form4_167813123996261.xml · nonDerivative · entry 1 Hauser Joseph W · CIK 0001909181 · Sr VP & GM Trauma & Deformity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,144 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 17,755 shares. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 08:07 UTC |
Odle Gregory AExecutive Vice President
|
SaleCommon Stock | 1,195 | $50.00 | $59,753.59 |
DisclosureSEC source: 0001425450-23-000016 · wf-form4_167542962959791.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,850 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 08:16 UTC |
Odle Gregory AExecutive Vice President
|
SaleCommon Stock | 80 | $47.00 | $3,760.00 |
DisclosureSEC source: 0001425450-23-000014 · wf-form4_167456617398289.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,045 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 08:10 UTC |
Odle Gregory AExecutive Vice President
|
SaleCommon Stock | 1,771 | $45.00 | $79,695.00 |
DisclosureSEC source: 0001425450-23-000012 · wf-form4_167396101744810.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,125 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 09, 2023 Filed Jan 10, 2023 11:53 UTC |
Odle Gregory AExecutive Vice President
|
SaleCommon Stock | 229 | $45.04 | $10,315.01 |
DisclosureSEC source: 0001425450-23-000010 · wf-form4_167336962174008.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| December 30, 2022 Filed Jan 10, 2023 16:52 UTC |
Bailey David RDirector · President and CEO
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000008 · wf-form5_167336951625566.xml · nonDerivative · entry 1 Bailey David R · CIK 0001719296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,505 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. F2 · balance_after: Includes restricted stock awards totaling 31,259 shares. Read SEC document |
| November 17, 2022 Filed Jan 10, 2023 11:50 UTC |
Throdahl Mark CDirector
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000006 · wf-form5_167336940764188.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,539 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. F2 · balance_after: Includes restricted stock awards totaling 25,689 shares. Read SEC document |
| November 16, 2022 Filed Jan 10, 2023 11:50 UTC |
Throdahl Mark CDirector
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000006 · wf-form5_167336940764188.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,839 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:29 UTC |
Pritzker Jennifer N.10% owner
|
OtherWarrants (right to buy) · Derivative | 1,525,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031656 · doc4.xml · derivative · entry 7 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F6 · derivative.exercise_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F6 · derivative.expiration_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"), a manager-managed limited liability company. As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:29 UTC |
Pritzker Jennifer N.10% owner
|
OtherCommon Stock | 1,525,000 | $0.00 | $457.50 |
DisclosureSEC source: 0000899243-22-031656 · doc4.xml · nonDerivative · entry 1 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,901,764 F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"), a manager-managed limited liability company. As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:34 UTC |
Squadron Capital LLC10% owner
Squadron Capital Holdings LLC10% owner
|
OtherWarrants (right to buy) · Derivative | 1,525,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031660 · doc4.xml · derivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:34 UTC |
Squadron Capital LLC10% owner
Squadron Capital Holdings LLC10% owner
|
OtherCommon Stock | 1,525,000 | $0.00 | $457.50 |
DisclosureSEC source: 0000899243-22-031660 · doc4.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,901,764 F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:31 UTC |
Pelizzon David RDirector · 10% owner
|
OtherWarrants (right to buy) · Derivative | 1,525,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031659 · doc4.xml · derivative · entry 3 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F2 · derivative.exercise_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F2 · derivative.expiration_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:31 UTC |
Pelizzon David RDirector · 10% owner
|
OtherCommon Stock | 1,525,000 | $0.00 | $457.50 |
DisclosureSEC source: 0000899243-22-031659 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,901,764 F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2022 Filed Feb 3, 2023 22:55 UTC |
Pelizzon David RDirector · 10% owner
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003913 · doc5.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,816 Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:14 UTC |
Schlotterback Terry DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 670 | $56.10 Strike: $30.97 | $37,587.00 |
DisclosureSEC source: 0001425450-22-000096 · wf-form4_166068083920447.xml · derivative · entry 3 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 670 shares Expires 2022-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:14 UTC |
Schlotterback Terry DDirector
|
Tax withholdingCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000096 · wf-form4_166068083920447.xml · nonDerivative · entry 2 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,956 F2 · shares: Shares sold to satisfy exercise price obligation. F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:14 UTC |
Schlotterback Terry DDirector
|
Exercise / conversionCommon Stock | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000096 · wf-form4_166068083920447.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 20:53 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseWarrants (right to buy) · Derivative | 1,525,000 | $55.00 Strike: $0.00 | $83,874,695.00 |
DisclosureSEC source: 0000899243-22-028652 · doc4.xml · derivative · entry 1 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,525,000 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F2 · ownership.nature: These securities are held directly by Squadron, a manager-managed limited liability company. As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:38 UTC |
Squadron Capital LLC10% owner
Squadron Capital Holdings LLC10% owner
|
PurchaseWarrants (right to buy) · Derivative | 1,525,000 | $55.00 Strike: $0.00 | $83,874,695.00 |
DisclosureSEC source: 0000899243-22-028658 · doc4.xml · derivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525,000 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days. F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:38 UTC |
Pelizzon David RDirector · 10% owner
|
PurchaseWarrants (right to buy) · Derivative | 1,525,000 | $55.00 Strike: $0.00 | $83,874,695.00 |
DisclosureSEC source: 0000899243-22-028657 · doc4.xml · derivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,525,000 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days. F2 · ownership.nature: These securities are held directly by Squadron. As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 17:22 UTC |
Ruf HaroldDirector
|
PurchaseCommon Stock | 1,235 | $39.45 | $48,720.75 |
DisclosureSEC source: 0001425450-22-000076 · wf-form4_165540010906875.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,824 F1 · balance_after: Shares are owned by the Donna Ruf DAP Trust dated July 30, 2020, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein Read SEC document |
| June 07, 2022 Filed Jun 10, 2024 20:05 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000056 · wk-form4_1718049921.xml · nonDerivative · entry 2 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 16,916 F1 · shares: Reflects gifting not previously reported currently held by The Last Chance Legacy Trust, dated April 3, 2023. Read SEC document |
| June 07, 2022 Filed Jun 10, 2024 20:05 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000056 · wk-form4_1718049921.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,731 F1 · shares: Reflects gifting not previously reported currently held by The Last Chance Legacy Trust, dated April 3, 2023. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 08:19 UTC |
Hughes Bryan WDirector
|
GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000072 · wf-form4_165425874490052.xml · nonDerivative · entry 1 Hughes Bryan W · CIK 0001719269 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,095 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 08:10 UTC |
Schlotterback Terry DDirector
|
GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000064 · wf-form4_165425821782931.xml · nonDerivative · entry 1 Schlotterback Terry D · CIK 0001719251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,659 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 08:13 UTC |
Unger KevinDirector
|
GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000066 · wf-form4_165425839790261.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,291 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 14:10 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000074 · wf-form4_165426540945364.xml · nonDerivative · entry 3 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 12,589 F2 · shares: On June 1, 2022, the reporting person had 1,400 of restricted shares which vested. Upon vesting these shares were distributed to the Donna Ruff DAP Trust dated July 30, 2020, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 14:10 UTC |
Ruf HaroldDirector
|
GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000074 · wf-form4_165426540945364.xml · nonDerivative · entry 2 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,092 F2 · shares: On June 1, 2022, the reporting person had 1,400 of restricted shares which vested. Upon vesting these shares were distributed to the Donna Ruff DAP Trust dated July 30, 2020, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 14:10 UTC |
Ruf HaroldDirector
|
GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000074 · wf-form4_165426540945364.xml · nonDerivative · entry 1 Ruf Harold · CIK 0001719213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,492 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.